NDC 0006-5331
WELIREG
Belzutifan
WELIREG is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Belzutifan.
| Product ID | 0006-5331_2e5ead48-073a-48ef-a8fd-e7f11f930618 |
| NDC | 0006-5331 |
| Product Type | Human Prescription Drug |
| Proprietary Name | WELIREG |
| Generic Name | Belzutifan |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-08-13 |
| Marketing Category | NDA / |
| Application Number | NDA215383 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | BELZUTIFAN |
| Active Ingredient Strength | 40 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0006-5331-01
90 TABLET, FILM COATED in 1 BOTTLE (0006-5331-01)
| Marketing Start Date | 2021-08-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
Trademark Results [WELIREG]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 WELIREG 88379214 not registered Live/Pending |
Merck Sharp & Dohme Corp. 2019-04-10 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.